Overview
Status
Active
Registry date
2016-10-12
Share capital
70,000.00 PLN
Registered address
ul. Heliotropów 29, 04-796 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 557 days for 2023).
- 2025not filed
- 202423/01/2026
- 202323/01/2026
- 202214/08/2023
- 202107/10/2022
- 202019/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 198.62kMedianUSD 3.20mAverageUSD 13.48m
Net profit
This companyUSD 5.21kMedianUSD 60.59kAverageUSD 247.11k
Operating costs
This companyUSD 191.96kMedianUSD 2.92mAverageUSD 12.83m
Assets
This companyUSD 22.62kMedianUSD 2.19mAverageUSD 10.93m
Industry
Authorized Representatives
Jan Tadeusz Olek – Management Board Member
Stanisław Piotr Olek – Attorney-in-fact
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jan Tadeusz Olekage 43 | 100 | $2,701.24 | 14.2857% |
Łukasz Stanisław Olekage 46 | 500 | $13,506.21 | 71.4286% |
Stanisław Piotr Olekage 36 | 100 | $2,701.24 | 14.2857% |
Łukasz Stanisław Olek, Jan Tadeusz Olek and Stanisław Piotr Olek hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 4, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $27,694$27,694 | Polski Fundusz Rozwoju S.A. | |
| Apr 24, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ScanmedS.A. | $266,523,177.15 | scanmed.pl | ||
| LUX Med Onkologiasp. z o.o. | $121,974,338.96 | onkologia.luxmed.pl | ||
| Szpital Wolski Im. Dr Anny Gostyńskiejsp. z o.o. | $66,853,476.48 | wolski.med.pl | ||
| Szpital Czerniakowskisp. z o.o. | $53,133,134.99 | szpitalczerniakowski.waw.pl | ||
| Sawimedsp. z o.o. | $4,507,040.08 | sawimed.pl | ||
| Ortopedikasp. z o.o. | $3,201,651.04 | ortopedika.pl | ||
| Timeless Chirurgia Plastycznasp. z o.o. | $1,290,613.78 | timeless.com.pl | ||
| SensinS.A. | $995,005.39 | sensinclinic.pl | ||
| Ackermann Caresp. z o.o. | $440,920.71 | ackermann.agency | ||
| Centrum Badań Medycznych Brand Medsp. z o.o. | $66,160.01 | brand-med.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-06-30 | Address change (Ul. Gen. Augusta Emila Fieldorfa "nila" 5a, 03-984, Warszawa → Ul. Heliotropów 29, 04-796, Warszawa) | |
| 2022-06-10 | Address change (Ul. Grójecka 216/192, 02-390, Warszawa → Ul. Gen. Augusta Emila Fieldorfa "nila" 5a, 03-984, Warszawa) | |
| 2019-11-18 | Address change (Aleja Księcia Józefa Poniatowskiego 1, 03-901, Warszawa → Ul. Grójecka 216/192, 02-390, Warszawa) | |
| 2019-04-15 | Address change (Ul. Żmigrodzka 18, 60-171, Poznań → Aleja Księcia Józefa Poniatowskiego 1, 03-901, Warszawa) | |
| 2017-12-08 | Address change (Os. Przemysława 23/13, 61-064, Poznań → Ul. Żmigrodzka 18, 60-171, Poznań) |
FAQ
The main business activity of Miracolo Clinic focuses on hospital activities.
The company was registered in the Polish National Court Register (KRS) on October 12, 2016.
The headquarters is located at: ul. Heliotropów 29, 04-796 Warszawa.
The share capital of the company is PLN 70,000 (approx. $18,909).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $198,623, representing a decrease of 5.3% compared to 2023.
Yes, the company recorded a net profit of $5,208 in 2024, meaning the company decreased its profit by 81.5%.
The largest operating cost category falls under other operating costs. This category amounted to $136,279 in 2024, representing 71% of all operating expenses.
Last updated: 2026-04-20
